Trulieve Cannabis Corp.
General ticker "TCNNF" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $1.0B (TTM average)
Trulieve Cannabis Corp. follows the US Stock Market performance with the rate: 45.6%.
Estimated limits based on current volatility of 5.0%: low 5.80$, high 6.40$
Factors to consider:
- Total employees count: 6000 (+11.1%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Industry immaturity, Expansion risks, Acquisition/divestiture risks, Agricultural risks, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [2.78$, 7.64$]
- 2025-12-31 to 2026-12-31 estimated range: [2.16$, 5.93$]
Financial Metrics affecting the TCNNF estimates:
- Positive: with PPE of -6.3 at the end of fiscal year the price was low
- Positive: 7.86 < Operating profit margin, % of 8.24
- Positive: Operating cash flow per share per price, % of 29.31 > 13.24
- Negative: negative Industry operating cash flow (median)
- Positive: Industry inventory ratio change (median), % of -1.41 <= -0.15
- Negative: Investing cash flow per share per price, % of -22.30 <= -14.38
- Positive: 41.86 < Shareholder equity ratio, % of 43.52 <= 63.39
- Positive: Inventory ratio change, % of 0 <= 0
Short-term TCNNF quotes
Long-term TCNNF plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $1,239.81MM | $1,129.19MM | $1,186.49MM |
| Operating Expenses | $1,207.40MM | $1,350.81MM | $1,088.71MM |
| Operating Income | $32.41MM | $-221.61MM | $97.78MM |
| Non-Operating Income | $-75.75MM | $-62.92MM | $-55.07MM |
| Interest Expense | $79.77MM | $81.57MM | $62.19MM |
| Income(Loss) | $-43.34MM | $-284.54MM | $42.71MM |
| Taxes | $161.82MM | $151.36MM | $197.59MM |
| Other Income(Loss) | $-47.56MM | $-97.24MM | $-5.70MM |
| Profit(Loss)* | $-205.10MM | $-527.99MM | $-155.10MM |
| Stockholders Equity | $1,927.70MM | $1,408.61MM | $1,249.03MM |
| Assets | $3,400.41MM | $2,729.05MM | $2,870.27MM |
| Operating Cash Flow | $23.10MM | $201.84MM | $271.48MM |
| Capital expenditure | $184.58MM | $55.49MM | $121.52MM |
| Investing Cash Flow | $-215.06MM | $-37.47MM | $-206.62MM |
| Financing Cash Flow | $177.80MM | $-175.59MM | $-33.44MM |
| Earnings Per Share** | $-1.10 | $-2.79 | $-0.82 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.